Modulight Spotlights: LASER-SHARP RESEARCH – October 2022
This month’s laser sharp nomination goes to Takuya Osada‘s team at Duke University Medical Center. Their impressive results on novel immunotherapy combination strategy for breast cancer was published in the Journal for ImmunoTherapy of Cancer. The team combined immune checkpoint blockage with HSP90-targeted light therapy using ML7710 medical laser. This combination resulted in strong activation of antitumor immunity and prolonged survival in syngeneic breast cancer models. Impressively, adding immune checkpoint blockers even resulted in an increased antitumor activity elsewhere, outside the local light-treated area, showing potential for treatment of disseminated disease and high clinical relevance. More about the study can be found from the article link below.
Modulight is very happy to be supporting this research. We would like to deliver our warmest congratulations to the research team!#LaserSharpResearch #breastcancer #immunotherapy #HeatShockProtein #targetedtherapy #immunecheckpoints #noveltherapies
Modulight products used:
About Modulight’s LASER-SHARP RESEARCH concept:
Modulight has launched a concept where our scientific board highlights cutting-edge scientific research articles from our customers. Important selection criteria are that Modulight and laser product are mentioned in the publication, the impact and relevance of the results, clinical translatability, as well as scientific quality of the journal. The nominated research groups will be rewarded to encourage the great work done.
Do you have questions or comments related to this LASER-SHARP RESEARCH nomination? Maybe your group has done significant research that your would like us to spotlight? Or would you like to request literature? Please drop us a line!